Maitreya Medica.

Market Cap: Micro Cap
Industry: Hospital
ISIN: INE0PLQ01011
NSEID: MAITREYA
BSEID:

INR

254.75

1.1 (0.43%)

BSENSE

Dec 05

BSE+NSE Vol: 4800

{
  "main_header": {
    "sid": 10039066,
    "name": "Maitreya Medica.",
    "stock_name": "Maitreya Medica.",
    "full_name": "Maitreya Medicare Ltd",
    "name_url": "stocks-analysis/maitreya-medica",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "254.75",
    "chg": 1.1,
    "chgp": "0.43%",
    "dir": 1,
    "prev_price": "253.65",
    "mcapval": "178.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "MAITREYA",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE0PLQ01011",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 4800,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/maitreya-medica-10039066-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Maitreya Medica. Sees Revision in Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/maitreya-medica-downgraded-to-strong-sell-by-marketsmojo-amid-deteriorating-fundamentals-3746499",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MaitreyaMedica_mojoScore_3746499.png",
        "date": "2025-12-04 11:08:19",
        "description": "Maitreya Medica., a microcap player in the hospital sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance from market analysts."
      },
      {
        "title": "Why is Maitreya Medica. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-maitreya-medica-fallingrising-3727186",
        "imagepath": "",
        "date": "2025-11-25 01:48:43",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock’s recent performance has been disappointing, with a one-week decline of 6.47%, significantly underperforming the Sensex’s marginal fall of 0.21% over the same period. Over the past month, Maitreya Medicare’s shares have slipped by 2.64%, while the Sensex gained 0.64%. The year-to-date figures reveal a stark contrast, with the stock down 27.50% against the Sensex’s robust 9.79% rise. Similarly, over the last year, the stock has lost 28.38%, whereas the benchmark index has appreciated by 8.58%. This persistent underperformance highlights the challenges the company faces in regaining investor confidence.</p>\n<p><strong>Technical Indicators and Trading Activity</strong></p>\n<p>On the technical front, Maitreya Medicare is tradi..."
      },
      {
        "title": "How has been the historical performance of Maitreya Medica.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-maitreya-medica-3726458",
        "imagepath": "",
        "date": "2025-11-24 23:30:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Trends</strong></p>\n<p>Examining the consolidated net sales from March 2022 to March 2025, Maitreya Medica's revenue has shown some volatility. The company recorded net sales of ₹49.41 crores in March 2022, which declined to ₹39.38 crores in March 2023 before partially recovering to ₹46.66 crores by March 2025. This indicates a challenging period in 2023, followed by a stabilisation in the subsequent years.</p>\n<p>Operating profit margins excluding other income peaked at 18.41% in March 2023 but declined to 10.42% by March 2025, signalling pressure on operational efficiency. Similarly, the profit after tax (PAT) margin followed a downward trend from 10.79% in 2023 to 4.01% in 2025, reflecting reduced net profitability.</p>\n<p>Profit after tax figures also mirror this patte..."
      },
      {
        "title": "Maitreya Medicare Quality Parameter Revision: A Detailed Analysis of Business Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/maitreya-medicare-quality-grade-downgrade-a-detailed-analysis-of-business-fundamentals-3714085",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MaitreyaMedicar_qualitydot_3714085.png",
        "date": "2025-11-19 08:00:33",
        "description": "Maitreya Medicare, a player in the hospital sector, has undergone a revision in its quality parameter evaluation, shifting from an average to a below average grade. This adjustment reflects changes in key business fundamentals such as return on equity (ROE), return on capital employed (ROCE), debt levels, and growth metrics, which are critical for investors analysing the company’s financial health and operational consistency."
      },
      {
        "title": "How has been the historical performance of Maitreya Medica.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-maitreya-medica-3713256",
        "imagepath": "",
        "date": "2025-11-18 23:03:12",
        "description": "Answer:\nThe historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years.\n\nBreakdown:\nMaitreya Medica's net sales have seen a decline from INR 49.41 crore in March 2022 to INR 46.66 crore in March 2025, with a peak of INR 47.80 crore in March 2024. Total operating income mirrored this trend, peaking in March 2024 before dropping to INR 46.66 crore in March 2025. The company's operating profit (PBDIT) also decreased from INR 7.82 crore in March 2023 to INR 5.45 crore in March 2025, reflecting a decline in operating profit margin from 18.41% to 10.42%. Profit before tax followed a similar downward trajectory, falling from INR 5.93 crore in March 2023 to INR 3.21 crore in March 2025. Consequently, profit after tax decreased from INR 4.25 crore in March 2023 to INR 1.87 crore in March 2025, resulting in a PAT margin decline from 10.79% to 4.01%. On the balance s..."
      },
      {
        "title": "Why is Maitreya Medica. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-maitreya-medica-fallingrising-3709446",
        "imagepath": "",
        "date": "2025-11-18 00:05:52",
        "description": "As of 17-Nov, Maitreya Medicare Ltd's stock price is currently at 260.55, reflecting a decline of 26.0 points or 9.07%. The stock has underperformed its sector today by 11.49%, despite showing higher performance than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average. Over the past week, the stock has gained 9.80%, but it has experienced a significant year-to-date decline of 22.49%. The company's ability to service debt is strong, indicated by a low Debt to EBITDA ratio of 0.30 times, and it has an attractive valuation with a Price to Book Value of 5.5. However, the stock's profits have fallen by 40% over the past year, contributing to its negative return of 21.97%.\n\nIn the broader market context, Maitreya Medicare Ltd's performance over the past week has outpaced the Sensex, which has only increased by 1.72%. However, the stock's year-to-date perfor..."
      },
      {
        "title": "How has been the historical performance of Maitreya Medica.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-maitreya-medica-3704272",
        "imagepath": "",
        "date": "2025-11-15 00:31:30",
        "description": "Answer:\nThe historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years.\n\nBreakdown:\nMaitreya Medica's net sales decreased slightly from INR 47.80 crore in March 2024 to INR 46.66 crore in March 2025, following a peak of INR 49.41 crore in March 2022 and a lower figure of INR 39.38 crore in March 2023. The total operating income mirrored this trend, remaining at INR 46.66 crore in March 2025. The total expenditure, excluding depreciation, decreased to INR 41.80 crore in March 2025 from INR 42.09 crore in March 2024. Operating profit (PBDIT) fell to INR 5.45 crore in March 2025 from INR 5.98 crore in the previous year, with a notable decline from INR 7.82 crore in March 2023. Profit before tax also decreased to INR 3.21 crore in March 2025, down from INR 3.90 crore in March 2024 and INR 5.93 crore in March 2023. Consequently, profit after tax dropped to INR ..."
      },
      {
        "title": "Why is Maitreya Medica. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-maitreya-medica-fallingrising-3699939",
        "imagepath": "",
        "date": "2025-11-13 23:59:46",
        "description": "As of 13-Nov, Maitreya Medicare Ltd is experiencing a price increase, currently at 288.65, reflecting a rise of 17.2 or 6.34%. The stock has shown strong performance today, outperforming its sector by 5.63%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Notably, there has been a significant increase in investor participation, with delivery volume rising by 301.96% compared to the 5-day average. Despite a year-to-date decline of 14.13% and a 15.89% drop over the past year, the company maintains a low Debt to EBITDA ratio of 0.30 times, indicating a strong ability to service debt, which may contribute positively to investor sentiment.\n\nIn the broader market context, Maitreya Medicare Ltd's short-term return of 25.01% over the past week significantly outpaces the Sensex's return of 1.45% during the same period. This stark contrast highlights the stock's rece..."
      },
      {
        "title": "How has been the historical performance of Maitreya Medica.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-maitreya-medica-3699811",
        "imagepath": "",
        "date": "2025-11-13 23:51:29",
        "description": "Answer:\nThe historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years.\n\nBreakdown:\nMaitreya Medica's net sales have seen a decline from 49.41 Cr in Mar'22 to 46.66 Cr in Mar'25, with a peak in Mar'24 at 47.80 Cr. Total operating income followed a similar trend, peaking at 49.41 Cr in Mar'22 and dropping to 46.66 Cr in Mar'25. The total expenditure, excluding depreciation, decreased from 46.05 Cr in Mar'22 to 41.80 Cr in Mar'25, contributing to an operating profit (PBDIT) that rose from 3.36 Cr in Mar'22 to 4.86 Cr in Mar'25, although it was higher at 7.25 Cr in Mar'23. Profit before tax also fluctuated, reaching 3.21 Cr in Mar'25, down from 5.93 Cr in Mar'23. Consequently, profit after tax decreased from 4.25 Cr in Mar'23 to 1.87 Cr in Mar'25. The company's total assets increased from 24.49 Cr in Mar'22 to 47.99 Cr in Mar'25, while total liabilities rose ..."
      }
    ],
    "total": 105,
    "sid": "10039066",
    "stock_news_url": "https://www.marketsmojo.com/news/maitreya-medicare-10039066"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Maitreya Medica. Sees Revision in Market Assessment Amid Mixed Financial Signals

2025-12-04 11:08:19

Maitreya Medica., a microcap player in the hospital sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance from market analysts.

Why is Maitreya Medica. falling/rising?

2025-11-25 01:48:43

Recent Price Movement and Market Comparison

The stock’s recent performance has been disappointing, with a one-week decline of 6.47%, significantly underperforming the Sensex’s marginal fall of 0.21% over the same period. Over the past month, Maitreya Medicare’s shares have slipped by 2.64%, while the Sensex gained 0.64%. The year-to-date figures reveal a stark contrast, with the stock down 27.50% against the Sensex’s robust 9.79% rise. Similarly, over the last year, the stock has lost 28.38%, whereas the benchmark index has appreciated by 8.58%. This persistent underperformance highlights the challenges the company faces in regaining investor confidence.

Technical Indicators and Trading Activity

On the technical front, Maitreya Medicare is tradi...

How has been the historical performance of Maitreya Medica.?

2025-11-24 23:30:02

Revenue and Profit Trends

Examining the consolidated net sales from March 2022 to March 2025, Maitreya Medica's revenue has shown some volatility. The company recorded net sales of ₹49.41 crores in March 2022, which declined to ₹39.38 crores in March 2023 before partially recovering to ₹46.66 crores by March 2025. This indicates a challenging period in 2023, followed by a stabilisation in the subsequent years.

Operating profit margins excluding other income peaked at 18.41% in March 2023 but declined to 10.42% by March 2025, signalling pressure on operational efficiency. Similarly, the profit after tax (PAT) margin followed a downward trend from 10.79% in 2023 to 4.01% in 2025, reflecting reduced net profitability.

Profit after tax figures also mirror this patte...

Maitreya Medicare Quality Parameter Revision: A Detailed Analysis of Business Fundamentals

2025-11-19 08:00:33

Maitreya Medicare, a player in the hospital sector, has undergone a revision in its quality parameter evaluation, shifting from an average to a below average grade. This adjustment reflects changes in key business fundamentals such as return on equity (ROE), return on capital employed (ROCE), debt levels, and growth metrics, which are critical for investors analysing the company’s financial health and operational consistency.

How has been the historical performance of Maitreya Medica.?

2025-11-18 23:03:12

Answer: The historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years. Breakdown: Maitreya Medica's net sales have seen a decline from INR 49.41 crore in March 2022 to INR 46.66 crore in March 2025, with a peak of INR 47.80 crore in March 2024. Total operating income mirrored this trend, peaking in March 2024 before dropping to INR 46.66 crore in March 2025. The company's operating profit (PBDIT) also decreased from INR 7.82 crore in March 2023 to INR 5.45 crore in March 2025, reflecting a decline in operating profit margin from 18.41% to 10.42%. Profit before tax followed a similar downward trajectory, falling from INR 5.93 crore in March 2023 to INR 3.21 crore in March 2025. Consequently, profit after tax decreased from INR 4.25 crore in March 2023 to INR 1.87 crore in March 2025, resulting in a PAT margin decline from 10.79% to 4.01%. On the balance s...

Why is Maitreya Medica. falling/rising?

2025-11-18 00:05:52

As of 17-Nov, Maitreya Medicare Ltd's stock price is currently at 260.55, reflecting a decline of 26.0 points or 9.07%. The stock has underperformed its sector today by 11.49%, despite showing higher performance than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average. Over the past week, the stock has gained 9.80%, but it has experienced a significant year-to-date decline of 22.49%. The company's ability to service debt is strong, indicated by a low Debt to EBITDA ratio of 0.30 times, and it has an attractive valuation with a Price to Book Value of 5.5. However, the stock's profits have fallen by 40% over the past year, contributing to its negative return of 21.97%. In the broader market context, Maitreya Medicare Ltd's performance over the past week has outpaced the Sensex, which has only increased by 1.72%. However, the stock's year-to-date perfor...

How has been the historical performance of Maitreya Medica.?

2025-11-15 00:31:30

Answer: The historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years. Breakdown: Maitreya Medica's net sales decreased slightly from INR 47.80 crore in March 2024 to INR 46.66 crore in March 2025, following a peak of INR 49.41 crore in March 2022 and a lower figure of INR 39.38 crore in March 2023. The total operating income mirrored this trend, remaining at INR 46.66 crore in March 2025. The total expenditure, excluding depreciation, decreased to INR 41.80 crore in March 2025 from INR 42.09 crore in March 2024. Operating profit (PBDIT) fell to INR 5.45 crore in March 2025 from INR 5.98 crore in the previous year, with a notable decline from INR 7.82 crore in March 2023. Profit before tax also decreased to INR 3.21 crore in March 2025, down from INR 3.90 crore in March 2024 and INR 5.93 crore in March 2023. Consequently, profit after tax dropped to INR ...

Why is Maitreya Medica. falling/rising?

2025-11-13 23:59:46

As of 13-Nov, Maitreya Medicare Ltd is experiencing a price increase, currently at 288.65, reflecting a rise of 17.2 or 6.34%. The stock has shown strong performance today, outperforming its sector by 5.63%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Notably, there has been a significant increase in investor participation, with delivery volume rising by 301.96% compared to the 5-day average. Despite a year-to-date decline of 14.13% and a 15.89% drop over the past year, the company maintains a low Debt to EBITDA ratio of 0.30 times, indicating a strong ability to service debt, which may contribute positively to investor sentiment. In the broader market context, Maitreya Medicare Ltd's short-term return of 25.01% over the past week significantly outpaces the Sensex's return of 1.45% during the same period. This stark contrast highlights the stock's rece...

How has been the historical performance of Maitreya Medica.?

2025-11-13 23:51:29

Answer: The historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years. Breakdown: Maitreya Medica's net sales have seen a decline from 49.41 Cr in Mar'22 to 46.66 Cr in Mar'25, with a peak in Mar'24 at 47.80 Cr. Total operating income followed a similar trend, peaking at 49.41 Cr in Mar'22 and dropping to 46.66 Cr in Mar'25. The total expenditure, excluding depreciation, decreased from 46.05 Cr in Mar'22 to 41.80 Cr in Mar'25, contributing to an operating profit (PBDIT) that rose from 3.36 Cr in Mar'22 to 4.86 Cr in Mar'25, although it was higher at 7.25 Cr in Mar'23. Profit before tax also fluctuated, reaching 3.21 Cr in Mar'25, down from 5.93 Cr in Mar'23. Consequently, profit after tax decreased from 4.25 Cr in Mar'23 to 1.87 Cr in Mar'25. The company's total assets increased from 24.49 Cr in Mar'22 to 47.99 Cr in Mar'25, while total liabilities rose ...

View All News